Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Citi
Deloitte
QuintilesIMS
AstraZeneca
Chinese Patent Office
Merck
Colorcon
Cerilliant

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205433

« Back to Dashboard

NDA 205433 describes KITABIS PAK, which is a drug marketed by Pulmoflow Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the KITABIS PAK profile page.

The generic ingredient in KITABIS PAK is tobramycin. There are eighteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the tobramycin profile page.
Summary for 205433
Tradename:KITABIS PAK
Applicant:Pulmoflow Inc
Ingredient:tobramycin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 205433
Ingredient-typeAminoglycosides
Medical Subject Heading (MeSH) Categories for 205433
Suppliers and Packaging for NDA: 205433
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KITABIS PAK tobramycin SOLUTION;INHALATION 205433 NDA Pari Respiratory Equipment 24492-850 N 24492-850-56
KITABIS PAK tobramycin SOLUTION;INHALATION 205433 NDA AUTHORIZED GENERIC Genericus, Inc. 70644-899 N 70644-899-99

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INHALATIONStrength300MG/5ML
Approval Date:Dec 2, 2014TE:ANRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Healthtrust
Harvard Business School
Express Scripts
QuintilesIMS
Teva
Boehringer Ingelheim
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.